Immuron (IMRN) Change in Cash (2016 - 2024)
Immuron (IMRN) recorded quarterly Change in Cash of -$2.6 million in Q4 2024, down 113.47% quarter-over-quarter from -$1.2 million in Q4 2023, and down 113.47% on a YoY basis from $19.3 million in Q1 2024.
Immuron (IMRN) Change in Cash (2016 - 2024) Analysis & Trends
Immuron's Change in Cash history runs 9 years deep, the most recent figure standing at -$2.6 million for Q4 2024.
- In Q4 2024, Change in Cash fell 113.47% year-over-year to -$2.6 million; the TTM figure through Dec 2024 stood at $10.0 million (down 72.5% YoY), while the FY2025 annual figure was -$8.8 million, down 59.19% from the prior year.
- Change in Cash was -$2.6 million for Q4 2024 at Immuron, down from -$1.2 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $23.9 million in Q4 2020 to a low of -$3.6 million in Q4 2022.
- Historically, Change in Cash has averaged $6.8 million across 5 years, with a median of -$1.2 million in 2023.
- The sharpest annual moves came in 2020 and 2022: Change in Cash jumped 8005.28% in 2020, then slumped 120.68% in 2022.
- A 5-year view of Change in Cash shows it stood at $23.9 million in 2020, then dropped by 26.8% to $17.5 million in 2021, then plunged by 120.68% to -$3.6 million in 2022, then soared by 66.28% to -$1.2 million in 2023, then sank by 113.47% to -$2.6 million in 2024.
- The last three Change in Cash figures came in at -$2.6 million (Q4 2024), -$1.2 million (Q4 2023), and -$3.6 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.60 Mn |
| Dec 31, 2023 | -1.22 Mn |
| Dec 31, 2022 | -3.62 Mn |
| Dec 31, 2021 | 17.49 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Dec 31, 2019 | -302,214.00 |
| Dec 31, 2018 | -424,901.00 |
| Dec 31, 2017 | -2.68 Mn |
| Dec 31, 2016 | 612,906.48 |